Results 41 to 50 of about 15,580 (201)

THE EXPERIENCE OF ENTECAVIR USE IN PATIENTS WITH HEPATITIS B VIRAL INFECTION ON AN OUTPATIENT BASIS

Alʹmanah Kliničeskoj Mediciny, 2016
Aim: To evaluate retrospectively the efficacy and safety of entecavir in treatment-naïve patients with hepatitis B viral infection.Materials and methods: Based on patient medical documentation, we analyzed the results of clinical, virologic and ...
L. I. Mel'nikova, L. Yu. Il'chenko
doaj   +1 more source

Auxiliary Liver Graft Can Be Protected From HBV Infection in HBsAg Positive Blood Circulation

Frontiers in Medicine, 2021
Auxiliary grafts have a high risk of Hepatitis B virus (HBV) infection in patients with chronic HBV-related diseases. Hepatitis B virus-related auxiliary partial orthotopic liver transplantation (APOLT) cases were reviewed to show the results of current ...
Lin Wei, Lin Wei, Lin Wei, Hai-Ming Zhang, Hai-Ming Zhang, Hai-Ming Zhang, Chi-Dan Wan, Wei Qu, Wei Qu, Wei Qu, Zhi-Gui Zeng, Zhi-Gui Zeng, Zhi-Gui Zeng, Ying Liu, Ying Liu, Ying Liu, Jun Xiong, Li-Ying Sun, Li-Ying Sun, Li-Ying Sun, Zhi-Jun Zhu, Zhi-Jun Zhu, Zhi-Jun Zhu   +22 more
doaj   +1 more source

Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B

Annals of Hepatology, 2016
Background and aims. CD4+ T cells play an important role in response to hepatitis B virus (HBV) infection. We investigated the change in CD4+ T-cell subpopulations and viral load in patients with chronic HBV infection who were treated with entecavir ...
Tian Zhan-Fei, You Zhong-Lan, Hong Yi, Kuang Xue-Mei, Wang Yu-Ming   +4 more
doaj   +1 more source

Kidney Transplantation From Donors with Hepatitis B [PDF]

, 2016
The growing demand for organ donors to supply the increasing number of patients on kidney waiting lists has led most transplant centers to develop protocols that allow safe use of organs from donors with special clinical situations previously regarded as
Ardita, Vincenzo, Corona, Daniela, Ekser, Burcin, Giaquinta, Alessia, Gozzo, Cecilia, Patanè, Marco, Sinagra, Nunziata, Veroux, Massimiliano, Veroux, Pierfrancesco, Zerbo, Domenico   +9 more
core   +1 more source

Congenital CMV Infection: Determination of Transplacental Passage of Aciclovir by Ex Vivo Placental Perfusion

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To quantify the transplacental transfer of aciclovir at an amount equivalent to 2 g of valaciclovir corresponding to the fractionated dosing regimen given four times daily used to reduce congenital cytomegalovirus (CMV) transmission and to treat the CMV‐infected fetus. Design Experimental ex vivo study.
Helyett Ollivier, Valentine Faure Bardon, Leo Froelicher Bournaud, Isidore Gaubert, Tiffany Guilleminot, Marianne Leruez‐Ville, Jean‐Marc Treluyer, Yves Ville, Gabrielle Lui, Julien Stirnemann   +9 more
wiley   +1 more source

Meta‐analysis: oral anti‐viral agents in adults with decompensated hepatitis B virus cirrhosis [PDF]

, 2012
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90203/1/apt4990 ...
Andreone, Belongia, Berg, Boxer, Chu, de Jongh, Fleischer, Fontana, Fontana, Fontana, Gane, Hadziyannis, Hadziyannis, Hann, Jadad, Kamath, Kao, Kim, Lange, Lavanchy, Liaw, Liaw, Liaw, Liaw, Liaw, Liaw, Lok, Manolakopoulos, Nikolaidis, Nishida, Osborn, Pellicelli, Perrillo, Perrillo, Raijnders, Rodriguez -Novoa, Schiff, Schiff, Shim, Tenney, Tseng, van Bommel, Villeneuve, von Elm, Wong, Woo, Yao, Zoulim   +47 more
core   +1 more source

Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression

Alimentary Pharmacology &Therapeutics, EarlyView.
Serum HBV RNA levels at viral suppression predict HCC development in nucleos(t)ide analogue‐treated patients with chronic hepatitis B, outperforming Hepatitis B core‐related antigen alone. ABSTRACT Background Despite achieving undetectable hepatitis B virus (HBV) DNA levels with nucleos(t)ide analogue (NA) therapy, patients with chronic hepatitis B ...
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Yuichi Koshiyama, Takanori Ito, Tomoyuki Akita, Junko Tanaka   +6 more
wiley   +1 more source

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis

Frontiers in Pharmacology
ObjectivesTo systematically evaluate the efficacy and safety of tenofovir and entecavir in chronic hepatitis B-related cirrhosis.MethodsA comprehensive search was conducted in databases including PubMed, Web of Science, Embase and Cochrane Library from ...
Lu Cao, Li Li, Lixing Yang, Nan Zhou, Yu Zhang   +4 more
doaj   +1 more source

Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients

Journal of the Formosan Medical Association, 2014
Several anti-viral drugs are approved for the treatment of hepatitis B virus (HBV) infection. However, whether quantitative hepatitis B surface antigen (qHBsAg) can predict the therapeutic response during long-term entecavir treatment remains unclear ...
Chia-Chi Wang, Tai-Chung Tseng, Pin-Chao Wang, Hans Hsienhong Lin, Jia-Horng Kao   +4 more
doaj   +1 more source

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients [PDF]

, 2016
Chronic hepatitis B (CHB) leads to cirrhosis and hepatocellular carcinoma (HCC). With a cohort of 1,206 CHB patients who visited Okayama University Hospital and related hospitals in 2011 and 2012, we compared the incidence rates of HCC among the patients
Fujioka, Shin-ichi, Ikeda, Fusao, Kariyama, Kazuya, Kobashi, Haruhiko, Miyatake, Hirokazu, Morimoto, Yoichi, Morimoto, Yuki, Moriya, Akio, Okamoto, Ryoichi, Seno, Tomonori, Takaguchi, Koichi, Takaki, Akinobu, Takayama, Hiroki, Toshimori, Junichi, Wada, Nozomu, Yabushita, Kazuhisa, Yamamoto, Kazuhide, Yasunaka, Tetsuya   +17 more
core   +1 more source